Source: MarketScreener

Aeglea: Aeglea BioTherapeutics : Submission of Matters to a Vote of Security Holders - Form 8-K

(marketscreener.com) Item 5.03 Amendments to Certificate of Incorporation. On November 21, 2023, Aeglea BioTherapeutics, Inc. implemented an increase in the number of authorized shares of its common stock, par value $0.0001...https://www.marketscreener.com/quote/stock/AEGLEA-BIOTHERAPEUTICS-IN-27114072/news/Aeglea-BioTherapeutics-Submission-of-Matters-to-a-Vote-of-Security-Holders-Form-8-K-45432905/?utm_medium=RSS&utm_content=20231124

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more